<DOC>
	<DOCNO>NCT02814045</DOCNO>
	<brief_summary>Alzheimer 's Disease ( AD ) prevalent neurodegenerative disease , manifest initial deficit episodic memory evolves global cognitive psychosocial dysfunction prevalence increase around world . Sleep disturbance frequent since early stage disease sleep fragmentation demonstrate increase production amyloid peptide ( AB ) ( main pathological hallmark ) non-demented population . Obstructive Sleep Apnea ( OSA ) , consist intermittent hypoxia sleep fragmentation , major health problem multiple systemic effect 's prevalent AD . However , influence comorbidity cognitive evolution AD patient remain unknown . The investigation neurobiological marker sleep record may reveal potential mechanism neurodegeneration explain influence sleep fragmentation and/or hypoxia cognitive decline . To fill gap , investigator perform multidisciplinary translational project assess progression symptom AD patient , diagnosis sleep disturbance new biomarkers progression disease . The present proposal go developed coordination different expertise range clinical research conduct medical neurologist , animal model molecular work , do experiment group mouse work .</brief_summary>
	<brief_title>Role Hypoxia Ans Sleep Fragmentation Alzheimer 's Disease . Sleep Fragmentation .</brief_title>
	<detailed_description>As AD OSA bidirectional relationship , OSA cause cerebral hypoxia sleep fragmentation favour deposition AB AD cause alteration sleep quality , investigator develop comprehensive project human patient animal model AD sleep fragmentation ( SF ) intermittent hypoxia ( IH ) . Investigators prospectively study consecutive patient new diagnosis mild probable Alzheimer 's Disease neurologist . Investigators define Alzheimer 's Disease accord National Institute Aging-Alzheimer 's Association criterion ( NIA-AA ) . All patient undergo routine neuropsychological battery , sleep polysomnography actigraphy registry , brain MRI , lumbar puncture blood biochemistry . Neuropsychological battery The following assessment use baseline 12 month : Alzheimer 's Disease Assessment Scale-cognitive ( ADAS-cog ) , Mini-Mental State Exam ( MMSE ) , Hachinski Scale , Digit Wechsler Adult Intelligence Scale ( WAIS- III ) ; Stroop Color-Word Interference Test ( Stroop ) ; Verbal fluency test ; Trail Making Test ( TMT ) A B ; California verbal learn test ( CVLT ) , Rey-Osterrieth Complex Figure Test ( RCFT ) , Cornell depression scale , neuropsychiatric inventory , caregiver burden scale EuroQol Test . CSF Cerebrospinal fluid obtain lumbar punction 8 , overnight fast . Amyloid beta 42 ( AB42 ) , tau phosphotau measure use enzyme-linked immunoabsorbent assay ( ELISA ) ( INNOTEST , Innogenetics ) . The cut-off base prior study laboratory . Also , ELISA employ detect level hypoxia-inducible factor 1-alpha ( HIF-1alpha vascular endothelial growth factor ( VEGF ) , nerve growth factor ( NGF ) brain-derived neurotrophic factor ( BDNF ) cerebrospinal fluid ( CSF ) . Sleep measurement To evaluate sleep characteristic patient PSG do patient baseline . The duration PSG 8 hour , 23 pm 7 pm . 6 channel EEG record reference two ear . Channels include 2 central electroencephalogram ( EEG ) , bilateral electrooculogram ( EOG ) , chin electromyogram ( EMG ) , thoracic abdominal respiratory effort , airflow ( use nasal-oral thermocouple nasal pressure record ) , finger pulse oximetry , electrocardiogram ( ECG ) , body position , bilateral piezoelectric sensor detect leg movement . Data evaluate trained technician , sleep stage assess 30-second epoch accord standard criterion . Apnea ( complete cessation airflow ) hypopnea ( discernible &gt; 30 % reduction airflow ) define occur 10 second longer accompany 4 % great oxygen desaturation . Arousals sleep define abrupt shift EEG frequency 3 second longer ; arousal rapid eye movement ( REM ) sleep required increase chin EMG activity . Sleep disorder breathing measure apnea-hypopnea index ( AHI ; number apnea plus hypopnea event per hour sleep ) , prevalent sleep-disordered breathing cod apnea -hypopnea index 15 event per hour . Calculated variable use index hypoxia include oxygen 4 % 15 &lt; 15 event per hour ; percentage sleep time oxygen saturation ( SaO2 ) &lt; 90 % 1 % sleep time &lt; 1 % sleep time SaO2 &lt; 90 % ; percentage sleep time apnea hypopnea ( &gt; 4 % oxygen desaturation cod tertiles ) . Calculated variable sleep fragmentation include arousal index ( AI ) define number arousal per hour sleep minute wake sleep onset ( WASO ) ( coded tertiles ) . Sleep duration measure total sleep time ( TST ) cod tertile . Investigators also measure REM stage I sleep duration.Patterns sleep circadian rhythm measure actigraph ( Actiwatch 2 ; Philips ) . Participants instruct wear actigraph nondominant wrist 14 day push marker actigraph whenever get bed . The quantity sleep measure total sleep time . The quality sleep measure sleep efficiency , total sleep time divide time bed , express percentage . A secondary measure sleep quality wake time sleep onset . Concurrently , participant fill sleep diary morning . The sleep diary query nap previous day , bedtime , sleep latency , nighttime awakening , wake time , opened comment . The number day per week least 1 nap take calculated `` nap day per week . '' Brain MRI All patient evaluate MRI perform use Siemens Avant 1.5 T , MRI scanner . The protocol perform include : 1 . Volumetric T1-weighted 3D multiplanar reconstruction , FoV 256 mm , slice thickness 1 mm , Time relapse ( TR ) 1600 m , TE 3,01 m , distance factor 50 % . T2 tse axial , FoV 230 mm , slice thickness 5 mm , TR 3560 m , TE 89 m , distance factor 30 % . Flair axial , FoV 230 mm , slice thickness 5 mm , TR 8000 m , Time exposition ( TE ) 94 m , distance factor 30 % . T2 gradient echo axial , FoV 230 mm , slice thickness 5 mm , TR 800 m , TE 26 m , distance factor 30 % . Echoplanar diffusion image , FoV 230 mm , slice thickness 5 mm , Time relapse 3902 m , TE 102 m , distance factor 40 % . T2 Turbo spin echo coronal , FoV 210 mm , slice thickness 5 mm , TR 3250 m , TE 100 m , distance factor 20 % . 2 . Perfusion - weight image ( PWI ) obtain use echo-planar imaging sequence ( FoV 230 mm , slice thickness 5 mm , TR 1439 m , TE 30 m ) injection gadolinium chelate ( Gadovist ) use automatic injector flow 4 ml/s . 3 . Spectroscopy Study evaluate cortical gray matter posterior cingulate right middle temporal gyrus use two echo time ( 31 136 m ) TR 2000 ms. Dimensions volume posterior cingulate 20 x 20 x 20 mm ( 8 cc ) right middle temporal gyrus 18 x 18 x 18 mm ( 5,8 cc ) . The posterior cingulate take reference due affected region patient Alzheimer SPECT study . Metabolomic lipidaemic analysis . Lipidaemic metabolomic analysis perform blood sample CSF . For metabolite extraction , sample deproteinized use cold methanol presence antioxidant internal standard . Lipids extract use chloroform/methanol presence antioxidant class-specific internal standard . Metabolite lipid extract subject mass spectrometry use High pressure liquid chromatography 1290 series couple Electrospray ionization-quadrupole reflection time-of-flight ( ESI-QTOF ) Mass spectrometry/Mass Spectrometry 6520 ( Agilent Technologies , Santa Clara , California , USA ) . The liquid chromatography-mass spectrometry metabolomic lipidemic analysis base previously describe method ( Jove et al. , 2013 ; Jove et al. , 2014 ) . Blood sample Blood sample obtain venous puncture 8 PSG . The sample process stored accordance Royal Decree 1716/2011 18th November 2011 authorization requirement operation biobanks biomedical research treatment biological sample human origin ( BOE No . 290 12.12.2011 ) . Determination molecular marker , metabolomics , lipidemic drawn . Commercial biomarkers ( TNF-alpha , Interleukine-6 Interleukine-8 ) , Thiobarbituric Acid Reactive Substances ( TBARS ) measure . Will perform genotyping APOE4 . Sample size calculation This observational cohort study , include group 72 patient OSA another 72 patient without OSA population patient mild initial AD making PSG . Patients recruit consecutively . If patient AD ability carry study sleep , investigator apply random selection ( web base tool ) . The sample size calculate accept alpha risk 0.05 beta risk 0.2 bilateral contrast detect difference equal great 3.5 unit ADAS-cog scale . It assume common standard deviation 7 . It estimate loss rate 12 % follow-up . Statistical analysis The standard statistical analysis perform SPSS statistical package , version 15.0 ( SPSS , Chicago , Illinois , USA ) . The result different variable express mean ± standard deviation value . The statistical significance difference group variable assess analysis variance ( ANOVA ) consider practice repeat measurement variable . To investigate existence correlation clinical variable use bivariate Spearman correlation test multivariate analysis .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Sleep Deprivation</mesh_term>
	<criteria>1 . Patients diagnose mild probable AD accord NIAAA criterion ( MMSE &gt; 20 ) . 2 . Informed Consent Form sign patient ( and/or applicable legal representative different responsible caregiver ) responsible caregiver . 3 . The patient knowledgeable reliable caregiver accompany patient clinic visit study . 4 . Absence visual hearing problem , investigator 's judgement , difficult compliance study procedure . 1 . Previous diagnosis OSA . 2 . Severe Alzheimer 's disease , type dementia patient mild Alzheimer 's disease current acetylcholinesterase inhibitor memantine treatment . 3 . Presence previously diagnose sleep disorder : narcolepsy , insomnia , chronic lack sleep . 4 . Having serious comorbidities : cancer , excessive intake alcohol ( &gt; 280 gr/week ) , severe depression , severe renal hepatic insufficiency , severe cardiac respiratory failure . 5 . Currently receive investigational drug device . 6 . Patient family decline take part . 7 . Disabling drowsiness justifiable cause . 8 . The patient MRI evidence hydrocephalus , stroke , spaceoccupying lesion , cerebral infection clinically significant central nervous system disease AD . 9 . The patient suffers mental retardation , organic mental disorder , mental disorder due general medical condition ( DSMIVTR™ criterion ) . 10 . The patient untreated vitamin B12 folate deficiency consider clinically significant , clinical laboratory evidence untreated thyroid disease . Patients vitamin B12 folate deficiency may enrol study provide supplement therapy &gt; 3 month prior Screening Visit stable . Patients thyroid disease may enrol study provide stable euthyroid . 11 . Patient betablockers , antidepressant , neuroleptic , hypnotic , remove 15 day conduct polysomnography ( PSG ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>biomarkers , sleep fragmentation , intermittent hypoxia</keyword>
</DOC>